BioWorld Asia

Jan. 3, 2007

European Drug Agency Predicts Another Bumper Year in 2007

BRUSSELS, Belgium - The London-based European Medicines Agency is expecting a high level of activity in 2007, and much of the work is likely to come from evaluation of new biotechnology medicine applications. (BioWorld International) Read More

On The Brink of Bankruptcy, GeneMedix Finds A Rescuer

New Breast Cancer Gene Moves Focus To Role of DNA Repair

Neuropharma Raises $41.7M For Alzheimer's Development

Cellectis Files IPO Prospectus On The Paris Stock Exchange

Protherics seeking $74.4 M And Expanded Product Line

SkyePharma Gets New Loan For Flutiform Development

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...